What Is The Pulmatrix (PULM)?
LEXINGTON, MASSACHUSETTS - Pulmatrix (PULM) has been on a tear of late and today's price action pleased investors that rode out the upward march. PULM is involved in treating respiratory diseases and investors are salivating at the possibility of looser EPA regulations that could lead to an increase in asthma, bronchitis, pneumonia and other ailments that affect the human lungs.
Tenax Therapeutics (TENX): Abandon All Hope!
MORRISVILLE, NORTH CAROLINA - Investors in TENX saw share price plummet like a stone dropped from a great height as the company reported less than stellar data. Bad phase 3 results will do it every time, especially to a small biotech company. Traders were pondering whether or not the company was worth a bounce play - or would the downward trend continue?
Ocera Therapeutics (OCRX): Timber!!!
PALO ALTO, CALIFORNIA - Shares of Ocera Therapeutics (OCRX) were down "Bigly" as investors took time to digest some bad data from the clinical stage biotech company. After losing over 60% of its value from Friday's close, investors and traders wondered if the bottom was in or if OCRX had more room to fall.
VRX Announcement Pleases Investors
LAVAL, CANADA - The share price of Valeant Pharmaceuticals (VRX) has been under intense selling pressure for well over a year due to a faulty business model that once exposed, sent the stock price into a seemingly never-ending tailspin. Now, the company is optimistic that its new drug will reverse the downward trend and give investors some much-needed confidence in the pharmaceutical company.